Cargando…

Reporter gene assays and chromatin-level assays define substantially non-overlapping sets of enhancer sequences

BACKGROUND: Transcriptional enhancers are essential for gene regulation, but how these regulatory elements are best defined remains a significant unresolved question. Traditional definitions rely on activity-based criteria such as reporter gene assays, while more recently, biochemical assays based o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindhorst, Daniel, Halfon, Marc S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837977/
https://www.ncbi.nlm.nih.gov/pubmed/36639739
http://dx.doi.org/10.1186/s12864-023-09123-9
_version_ 1784869186408808448
author Lindhorst, Daniel
Halfon, Marc S.
author_facet Lindhorst, Daniel
Halfon, Marc S.
author_sort Lindhorst, Daniel
collection PubMed
description BACKGROUND: Transcriptional enhancers are essential for gene regulation, but how these regulatory elements are best defined remains a significant unresolved question. Traditional definitions rely on activity-based criteria such as reporter gene assays, while more recently, biochemical assays based on chromatin-level phenomena such as chromatin accessibility, histone modifications, and localized RNA transcription have gained prominence. RESULTS: We examine here whether these two types of definitions, activity-based and chromatin-based, effectively identify the same sets of sequences. We find that, concerningly, the overlap between the two groups is strikingly limited. Few of the data sets we compared displayed statistically significant overlap, and even for those, the degree of overlap was typically small (below 40% of sequences). Moreover, a substantial batch effect was observed in which experiment set rather than experimental method was a primary driver of whether or not chromatin-defined enhancers showed a strong overlap with reporter gene-defined enhancers. CONCLUSIONS: Our results raise important questions as to the appropriateness of both old and new enhancer definitions, and suggest that new approaches are required to reconcile the poor agreement among existing methods for defining enhancers. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12864-023-09123-9.
format Online
Article
Text
id pubmed-9837977
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-98379772023-01-14 Reporter gene assays and chromatin-level assays define substantially non-overlapping sets of enhancer sequences Lindhorst, Daniel Halfon, Marc S. BMC Genomics Research BACKGROUND: Transcriptional enhancers are essential for gene regulation, but how these regulatory elements are best defined remains a significant unresolved question. Traditional definitions rely on activity-based criteria such as reporter gene assays, while more recently, biochemical assays based on chromatin-level phenomena such as chromatin accessibility, histone modifications, and localized RNA transcription have gained prominence. RESULTS: We examine here whether these two types of definitions, activity-based and chromatin-based, effectively identify the same sets of sequences. We find that, concerningly, the overlap between the two groups is strikingly limited. Few of the data sets we compared displayed statistically significant overlap, and even for those, the degree of overlap was typically small (below 40% of sequences). Moreover, a substantial batch effect was observed in which experiment set rather than experimental method was a primary driver of whether or not chromatin-defined enhancers showed a strong overlap with reporter gene-defined enhancers. CONCLUSIONS: Our results raise important questions as to the appropriateness of both old and new enhancer definitions, and suggest that new approaches are required to reconcile the poor agreement among existing methods for defining enhancers. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12864-023-09123-9. BioMed Central 2023-01-13 /pmc/articles/PMC9837977/ /pubmed/36639739 http://dx.doi.org/10.1186/s12864-023-09123-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Lindhorst, Daniel
Halfon, Marc S.
Reporter gene assays and chromatin-level assays define substantially non-overlapping sets of enhancer sequences
title Reporter gene assays and chromatin-level assays define substantially non-overlapping sets of enhancer sequences
title_full Reporter gene assays and chromatin-level assays define substantially non-overlapping sets of enhancer sequences
title_fullStr Reporter gene assays and chromatin-level assays define substantially non-overlapping sets of enhancer sequences
title_full_unstemmed Reporter gene assays and chromatin-level assays define substantially non-overlapping sets of enhancer sequences
title_short Reporter gene assays and chromatin-level assays define substantially non-overlapping sets of enhancer sequences
title_sort reporter gene assays and chromatin-level assays define substantially non-overlapping sets of enhancer sequences
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837977/
https://www.ncbi.nlm.nih.gov/pubmed/36639739
http://dx.doi.org/10.1186/s12864-023-09123-9
work_keys_str_mv AT lindhorstdaniel reportergeneassaysandchromatinlevelassaysdefinesubstantiallynonoverlappingsetsofenhancersequences
AT halfonmarcs reportergeneassaysandchromatinlevelassaysdefinesubstantiallynonoverlappingsetsofenhancersequences